HLTH News and Press, Cue Health Inc. From 10/06/23

Cue Health founder and investor, Kelly Day, and certain other stockholders Calls on the Board to reign in undisciplined expansion and cut expenditures Board should include direct stockholder representation to hold management to account Kelly Day and other concerned stockholders ...

In largest-of-its-kind clinical study on asymptomatic people, Cue demonstrated 99.4% accuracy compared to lab-based PCR Cue Health (Nasdaq: HLTH), a healthcare technology company, announced today the peer-reviewed publication of an independent clinical study - the largest of its kin...

2023-09-21 17:13:02 ET More on Cue Health Seeking Alpha’s Quant Rating on Cue Health Historical earnings data for Cue Health Financial information for Cue Health Cue Health Inc. (HLTH) Q2 2023 Earnings Call Transcript Cue Health awarded $28M BA...

Board of Directors Takes Action to Protect Long-Term Value for All Shareholders Rights Plan Responds to Significant Third-Party Share Accumulation Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that its Board of Directors has unanimously approved the...

2023-08-31 11:48:35 ET More on Cue Health Cue Health Inc. ( HLTH ) Q2 2023 Earnings Call Transcript Cue Health awarded $28M BARDA contract FDA approves Cue Health's at-home COVID-19 test Cue Health downgraded to neutral at Goldman Sachs on post-COVID envi...

2023-08-09 22:17:05 ET Cue Health Inc. (HLTH) Q2 2023 Earnings Conference Call August 09, 2023 04:30 PM ET Company Participants Lorna Williams - IR Ayub Khattak - Co-Founder, President, CEO & Chairman Aasim Javed - CFO Conference Call Participants ...

2023-08-09 16:47:13 ET Cue Health press release ( NASDAQ: HLTH ): Q2 Non-GAAP EPS of -$0.51 beats by $0.01 . Revenue of $10M (-88.6% Y/Y) beats by $1.08M . Shares +2.05% . Cue Health expects third quarter 2023 revenues in the range of $11 million to $13...

Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the second quarter 2023. Recent Highlights Reported second quarter total revenue of $10 million at the top-end of our guidance. Received landmark first, over-the-cou...

2023-08-05 16:00:22 ET The US could see the largest number of approvals for medtech devices in around 10 years given the high number of approvals the US FDA granted in the first half of 2023. The agency's Center for Devices and Radiological Health in H1 approved or cleared 45 new device...

2023-08-04 08:18:04 ET More on Cue Health FDA approves Cue Health's at-home COVID-19 test Cue Health downgraded to neutral at Goldman Sachs on post-COVID environment Cue Health wins FDA emergency nod for mpox test Cue Health partners with Pfizer on providing ...